Clinical trial modeling and simulation - Work in progress

Drug Information Journal

Volumn 32, Issue 4, 1998, Pages 971-976

  Krall, Ronald L ^a   Engleman, Kurt H ^a   Ko, Hui C ^c   Peck, Carl C ^b  

^a ASTRAZENECA   (United Kingdom)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

Clinical trial modeling; Clinical trial simulation; Computer assisted trial design; Drug development process; Pharmacokinetic pharmacodynamic modeling

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS;

CENTRAL NERVOUS SYSTEM; CLINICAL RESEARCH; CLINICAL TRIAL; COMPUTER MODEL; COMPUTER SIMULATION; DRUG RESEARCH; HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW;

EID: 0031741583     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159803200415     Document Type: Review

References (6)

1. Beal SL, Sheiner LB. NONMEM User's Guide Part I (continued): User's Basic Guide. San Francisco, CA: University of California; 1979.
2. Hale M, Gillespie WR, Gupta SK, Tuk B, Holford NH. Clinical Trial Simulation (continued): Streamlining your drug development process. Appl Clin Trials. 1996;5(8):35-40.
3. Gieschke R, Reigner BG, Steimer J-L. Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modelling. Int J Clin Pharmacol Ther. 1997;35(10):469-474.
4. Gooley TA, Martin PJ, Fisher LD, Pettinger M. Simulation as a design tool for Phase I/II clinical trials (continued): An example from bone marrow transplantation. Control Clin Trials. 1994;15:450-462.
5. Sheiner LB, Hashimoto Y, Beal SL. A simulation study comparing designs for dose ranging. Stat Med. 1991;10:303-321.
6. Peck CC, Desjardins RE. Simulation of clinical trials (continued): Encouragement and caution. App Clin Trials. 1996;5(9):30-32.